Macquarie Group
MED icon

Macquarie Group’s Medifast MED Stock Holding History

Macquarie Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,133
Closed -$2.83M – 1929
2023
Q4 		$2.83M Buy
42,133
+807
+2% +$56.2K ﹤0.01% 1124
2023
Q3 		$3.09M Buy
41,326
+8,292
+25% +$736K ﹤0.01% 1046
2023
Q2 		$3.04M Buy
33,034
+17,977
+119% +$1.6M ﹤0.01% 1057
2023
Q1 		$1.56M Buy
+15,057
New +$1.67M ﹤0.01% 1244
2022
Q4 		– Sell
-444
Closed -$64K – 1973
2022
Q3 		$64K Sell
444
-146
-25% -$20.9K ﹤0.01% 1883
2022
Q2 		$107K Hold
590
– – ﹤0.01% 1853
2022
Q1 		$101K Hold
590
– – ﹤0.01% 1945
2021
Q4 		$124K Sell
590
-44
-7% -$9.1K ﹤0.01% 1870
2021
Q3 		$122K Buy
634
+106
+20% +$26.1K ﹤0.01% 1923
2021
Q2 		$149K Buy
528
+225
+74% +$61K ﹤0.01% 1853
2021
Q1 		$64K Sell
303
-144
-32% -$34.5K ﹤0.01% 2014
2020
Q4 		$88K Hold
447
– – ﹤0.01% 1899
2020
Q3 		$74K Hold
447
– – ﹤0.01% 1856
2020
Q2 		$62K Sell
447
-553
-55% -$50.8K ﹤0.01% 1879
2020
Q1 		$62K Hold
1,000
– – ﹤0.01% 1773
2019
Q4 		$110K Hold
1,000
– – ﹤0.01% 1759
2019
Q3 		$104K Sell
1,000
-1,000
-50% -$107K ﹤0.01% 1723
2019
Q2 		$257K Buy
+2,000
New +$278K ﹤0.01% 1533
2019
Q1 		– Sell
-339
Closed -$42K – 1888
2018
Q4 		$42K Buy
339
+100
+42% +$17.1K ﹤0.01% 1626
2018
Q3 		$53K Sell
239
-978
-80% -$198K ﹤0.01% 1715
2018
Q2 		$195K Sell
1,217
-3,300
-73% -$422K ﹤0.01% 1666
2018
Q1 		$422K Buy
4,517
+1,317
+41% +$98.4K ﹤0.01% 1445
2017
Q4 		$223K Sell
3,200
-1,300
-29% -$86.2K ﹤0.01% 1703
2017
Q3 		$267K Buy
+4,500
New +$224K ﹤0.01% 1657

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Macquarie Group's MED Position: Q1 2024 in Review

Macquarie Group sold out of Medifast (MED) in Q1 2024, closing a stake of 42,133 shares — an estimated $2.83M sold.

Macquarie Group first reported a position in MED in Q3 2017 and held it in 24 quarters. The position peaked at $3.09M in Q3 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Macquarie Group reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Macquarie Group sold 42,133 Medifast shares in Q1 2024, an estimated $2.83M.
  • Macquarie Group first reported a position in Medifast in Q3 2017 and held it in 24 quarters.
  • Macquarie Group's Medifast position peaked at $3.09M in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Macquarie Group's 13F filing for Q1 2024, filed 14 May 2024.